Tecentriq 1,200 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FL1X0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,012
Award facts
- Contract value 100% obligated
- $26,011.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,011.96 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Tecentriq 1,200 mg/20 ml vials. The contract was awarded on September 4, 2025, with an ultimate completion date of September 25, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026, which authorizes firm fixed-price orders for comprehensive pharmaceutical supplies supporting military health facilities worldwide.
Tecentriq, an oncology medication used in cancer treatment protocols, represents one of numerous specialty pharmaceutical products within DMS Pharmaceutical Group's extensive federal portfolio. The company has established itself as a critical supplier in the Department of Defense pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for federal contracts across multiple product categories ranging from prescription drugs to biologics and medical consumables. The Park Ridge, Illinois location serves as the place of performance for this delivery order, supporting DLA's mission to provide pharmaceutical supplies to military healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FL1X0?
SPE2DB25FL1X0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FL1X0 worth?
The government has obligated $26,012 on SPE2DB25FL1X0.
Is contract SPE2DB25FL1X0 an order under another contract?
Yes. SPE2DB25FL1X0 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL1X0 competed?
The extent of competition for SPE2DB25FL1X0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award